AFT Pharmaceuticals (AFT.NZ) - EPS (earnings per share)

EPS in 2016 (TTM): -£0.23

According to AFT Pharmaceuticals's latest financial reports the company's current EPS (TTM) is £0.06053. In 2026 the company made an earnings per share (EPS) of £0.06053 an increase over its 2025 EPS that were of £0.04685.

EPS history for AFT Pharmaceuticals from 2016 to 2016

Annual EPS

Year	EPS	Change
2026	£0.06053	29.19%
2025	£0.04685	-30.54%
2024	£0.06745	43.38%
2023	£0.04704	-52.46%
2022	£0.09896	150.53%
2021	£0.03950	-32.24%
2020	£0.05829	-556.72%
2019	-£0.01276	-81.94%
2018	-£0.07066	-29.41%
2017	-£0.10	-59.89%
2016	-£0.25

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for AFT Pharmaceuticals (AFT.NZ)